Literature DB >> 31049575

MOSClip: multi-omic and survival pathway analysis for the identification of survival associated gene and modules.

Paolo Martini1, Monica Chiogna2, Enrica Calura1, Chiara Romualdi1.   

Abstract

Survival analyses of gene expression data has been a useful and widely used approach in clinical applications. But, in complex diseases, such as cancer, the identification of survival-associated cell processes - rather than single genes - provides more informative results because the efficacy of survival prediction increases when multiple prognostic features are combined to enlarge the possibility of having druggable targets. Moreover, genome-wide screening in molecular medicine has rapidly grown, providing not only gene expression but also multi-omic measurements such as DNA mutations, methylation, expression, and copy number data. In cancer, virtually all these aberrations can contribute in synergy to pathological processes, and their measurements can improve a patient's outcome and help in diagnosis and treatment decisions. Here, we present MOSClip, an R package implementing a new topological pathway analysis tool able to integrate multi-omic data and look for survival-associated gene modules. MOSClip tests the survival association of dimensionality-reduced multi-omic data using multivariate models, providing graphical devices for management, browsing and interpretation of results. Using simulated data we evaluated MOSClip performance in terms of false positives and false negatives in different settings, while the TCGA ovarian cancer dataset is used as a case study to highlight MOSClip's potential.
© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Year:  2019        PMID: 31049575      PMCID: PMC6698707          DOI: 10.1093/nar/gkz324

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  55 in total

Review 1.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

Review 2.  Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer.

Authors:  Johanne I Weberpals; Madhuri Koti; Jeremy A Squire
Journal:  Cancer Genet       Date:  2011-10

3.  Similarity network fusion for aggregating data types on a genomic scale.

Authors:  Bo Wang; Aziz M Mezlini; Feyyaz Demir; Marc Fiume; Zhuowen Tu; Michael Brudno; Benjamin Haibe-Kains; Anna Goldenberg
Journal:  Nat Methods       Date:  2014-01-26       Impact factor: 28.547

4.  Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.

Authors:  Kumardeep Chaudhary; Olivier B Poirion; Liangqun Lu; Lana X Garmire
Journal:  Clin Cancer Res       Date:  2017-10-05       Impact factor: 12.531

5.  Most random gene expression signatures are significantly associated with breast cancer outcome.

Authors:  David Venet; Jacques E Dumont; Vincent Detours
Journal:  PLoS Comput Biol       Date:  2011-10-20       Impact factor: 4.475

Review 6.  Matrix metalloproteinases in stem cell regulation and cancer.

Authors:  Kai Kessenbrock; Chih-Yang Wang; Zena Werb
Journal:  Matrix Biol       Date:  2015-02-03       Impact factor: 11.583

7.  Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.

Authors:  Matthew Ruffalo; Mehmet Koyutürk; Roded Sharan
Journal:  PLoS Comput Biol       Date:  2015-12-18       Impact factor: 4.475

8.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.

Authors:  Jianfang Liu; Tara Lichtenberg; Katherine A Hoadley; Laila M Poisson; Alexander J Lazar; Andrew D Cherniack; Albert J Kovatich; Christopher C Benz; Douglas A Levine; Adrian V Lee; Larsson Omberg; Denise M Wolf; Craig D Shriver; Vesteinn Thorsson; Hai Hu
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

9.  Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.

Authors:  Wei Zhang; Takayo Ota; Viji Shridhar; Jeremy Chien; Baolin Wu; Rui Kuang
Journal:  PLoS Comput Biol       Date:  2013-03-21       Impact factor: 4.475

10.  Copy number signatures and mutational processes in ovarian carcinoma.

Authors:  Geoff Macintyre; Teodora E Goranova; Dilrini De Silva; Darren Ennis; Anna M Piskorz; Matthew Eldridge; Daoud Sie; Liz-Anne Lewsley; Aishah Hanif; Cheryl Wilson; Suzanne Dowson; Rosalind M Glasspool; Michelle Lockley; Elly Brockbank; Ana Montes; Axel Walther; Sudha Sundar; Richard Edmondson; Geoff D Hall; Andrew Clamp; Charlie Gourley; Marcia Hall; Christina Fotopoulou; Hani Gabra; James Paul; Anna Supernat; David Millan; Aoisha Hoyle; Gareth Bryson; Craig Nourse; Laura Mincarelli; Luis Navarro Sanchez; Bauke Ylstra; Mercedes Jimenez-Linan; Luiza Moore; Oliver Hofmann; Florian Markowetz; Iain A McNeish; James D Brenton
Journal:  Nat Genet       Date:  2018-08-13       Impact factor: 38.330

View more
  3 in total

1.  Summarizing RNA-Seq Data or Differentially Expressed Genes Using Gene Set, Network, or Pathway Analysis.

Authors:  Enrica Calura; Paolo Martini
Journal:  Methods Mol Biol       Date:  2021

2.  Performance Comparison of Deep Learning Autoencoders for Cancer Subtype Detection Using Multi-Omics Data.

Authors:  Edian F Franco; Pratip Rana; Aline Cruz; Víctor V Calderón; Vasco Azevedo; Rommel T J Ramos; Preetam Ghosh
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 3.  A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research.

Authors:  Efstathios Iason Vlachavas; Jonas Bohn; Frank Ückert; Sylvia Nürnberg
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.